Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has provided an update.
Wai Chun Bio-Technology Limited has announced a revised timetable for its proposed capital reorganisation and connected transaction involving alterations to existing convertible bonds. The effective date for the capital reorganisation has been postponed to 29 September 2025, with the commencement of dealings in new ordinary shares expected on the same day. This delay is due to the additional time required for court orders and registration processes. The changes in the timetable are indicative and may be subject to further adjustments, impacting stakeholders’ planning and expectations.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company incorporated in the Cayman Islands, focusing on the biotechnology industry. It operates with a limited liability structure and is listed on the Stock Exchange of Hong Kong under stock code 660.
Average Trading Volume: 353,580
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.95M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.